Subscribe for free to our flagship newsletter, CDR: This Week in Retail, for news and insights from the voice of retail pharmacy.

Skip to content

Pharmacy

EnvisionRxOptions names Robson president

EnvisionRxOptions names Robson president

CAMP HILL, Pa. – EnvisionRxOptions, a wholly-owned subsidiary of Rite Aid and a leading pharmacy services and benefits company, announced Monday the appointment of Dan Robson as the company’s president. Robson will lead all aspects of EnvisionRxOptions operations.

House passes bill to lower drug prices

House passes bill to lower drug prices

On Thursday The House passed a bill aimed at lowering prescription drug prices, a step toward a long-held Democratic goal that was met with sharp Republican resistance. The bill passed on a largely party-line vote of 230-192.

CVS Health giving $750K to California Harm Reduction Coalition

CVS Health giving $750K to California Harm Reduction Coalition

As part of its commitment to building healthier communities, CVS Health announced Thursday it will be providing $750,000 over the next three years to the national Harm Reduction Coalition to improve the health and wellness of California residents impacted by prescription opioid misuse and abuse.

WBA and McKesson to create German wholesale joint venture

WBA and McKesson to create German wholesale joint venture

Walgreens Boots Alliance (WBA) and McKesson Corp. on Thursday signed an agreement to create a joint venture that will combine their respective pharmaceutical wholesale businesses in Germany with Alliance Healthcare Deutschland and GEHE Pharma Handel.

Nambe Drugs now offers AllerPops for allergy sufferers

Nambe Drugs now offers AllerPops for allergy sufferers

Nambe Drugs, a family-owned pharmacy located in Los Alamos and Santa Fe, is now carrying AllerPops, a natural allergy remedy that works by correcting the underlying cause of allergies instead of masking the symptoms. “I think it’s going to be a very effective product.

Pharmacy coalition applauds drug pricing act

Pharmacy coalition applauds drug pricing act

A coalition of national pharmacy groups on Tuesday applauded the latest version of the bipartisan Prescription Drug Pricing Reduction Act, released Friday by the Senate Finance Committee, which they say addresses backdoor clawback fees charged by large pharmacy benefit managers (PBMs) that are shutt

Diplomat Pharmacy agrees to $300 million buyout by UnitedHealth

Diplomat Pharmacy agrees to $300 million buyout by UnitedHealth

UnitedHealth Group pharmacy benefit manager OptumRx on Monday announced plans to purchase specialty drug provider Diplomat Pharmacy Inc. for about $300 million. The news comes amid continued financial struggles for Diplomat. In the third quarter, the company reported a $177 million net loss.

Merck to buy ArQule, advancing leadership in oncology

Merck to buy ArQule, advancing leadership in oncology

Merck and ArQule announced Monday that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire ArQule for $20 per share in cash for an approximate total equity value of $2.7 billion.